The Translational Genomics Research Institute

The Translational Genomics Research Institute (TGen), is a non-profit genomics research institute established in 2002 by Jeffrey Trent, the founding Scientific Director of the National Human Genome Research Institute (NHGRI), in Phoenix, Arizona, United States. TGen seeks to employ genetic discoveries to improve disease outcomes by developing smarter diagnostics and targeted therapeutics. TGen conducts research on a number of human disorders including Alzheimer's disease, Autism, Parkinson's, Diabetes and numerous forms of cancer and a variety of other complex human diseases. This internationally recognized institute has helped to generate a strong foundation for Arizona's growing role in scientific research and cutting edge biotechnology. The emerging field of translational genomics research harnesses the power of new discoveries resulting from the Human Genome Project and applying them to the development of improved diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.

Address
Phoenix, Arizona, United States of America
Website
http://www.tgen.org/

Subscribe to rss feed

Evolution

Birds take tRNA efficiency to new heights

Birds have been shaped by evolution in many ways that have made them distinct from their vertebrate cousins. Over millions of years of evolution, our feathered friends have taken to the skies, accompanied by unique changes ...

Automotive

How to test-drive vehicle technology

New vehicles are brimming with technology that can enhance convenience, connectivity and driver safety. But the tech can also be unfamiliar to car shoppers, especially those who haven't purchased a vehicle in the past five ...

Diseases, Conditions, Syndromes

Mumbai imposes strict virus restrictions as infections surge

The teeming metropolis of Mumbai and other parts of Maharashtra, the Indian state worst hit by the pandemic, face stricter restrictions for 15 days starting Wednesday in an effort to stem the surge of coronavirus infections.

Vaccination

EU turns to BioNTech/Pfizer after J&J vaccine suspension

The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, its chief Ursula von der Leyen said Wednesday.

Diseases, Conditions, Syndromes

Thailand's daily COVID infections hit record, topping 1,300

Thailand reported more than 1,300 new COVID-19 infections on Wednesday, setting another daily record and adding pressure on the government to speed up a nearly nonexistent vaccination drive and do more to control a surge ...

Business

EU court rejects 2 Ryanair challenges of airline subsidies

A top European Union court dealt another blow to Ryanair on Wednesday and rejected the low-cost carrier's arguments that the aid Sweden, Denmark and Finland gave two other airlines to get through the COVID-19 crisis was illegal.